000 | 01033 a2200301 4500 | ||
---|---|---|---|
005 | 20250513165416.0 | ||
264 | 0 | _c19990421 | |
008 | 199904s 0 0 eng d | ||
022 | _a0277-0008 | ||
024 | 7 |
_a10.1592/phco.19.3.196.30913 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRomanelli, F | |
245 | 0 | 0 |
_aHydroxyurea to inhibit human immunodeficiency virus-1 replication. _h[electronic resource] |
260 |
_bPharmacotherapy _cFeb 1999 |
||
300 |
_a196-204 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV-1 _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxyurea _xpharmacology |
650 | 0 | 4 |
_aVirus Replication _xdrug effects |
700 | 1 | _aPomeroy, C | |
700 | 1 | _aSmith, K M | |
773 | 0 |
_tPharmacotherapy _gvol. 19 _gno. 2 _gp. 196-204 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.19.3.196.30913 _zAvailable from publisher's website |
999 |
_c9992036 _d9992036 |